Transition from IV to subcutaneous prostacyclin: Premature withdrawal?

Chest

Volumn 132, Issue 3, 2007, Pages 741-743

  Shapiro, Shelley ^a   Hill, Nicholas S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; PROSTACYCLIN; UNIPROST;

DRUG ADMINISTRATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NOTE; PULMONARY HYPERTENSION; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIHYPERTENSIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; EPOPROSTENOL; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 35448999290     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.07-1992     Document Type: Editorial

References (7)

1. Vachiery JL, Hill N, Zwicke D, et al. Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension. Chest 2002; 121:1561-1565 (Pubitemid 34499671)
2. Suleman N, Frost A. Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension. Chest 2004; 126:808-815 (Pubitemid 39258035)
3. Steiner MK, Preston IR, Klinger JR, et al. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study. Chest 2006; 130:1471-1480 (Pubitemid 44786742)
4. Rubenfire M, McLaughlin VV, Roblee A, et al. Transition from epoprostenol to treprostinil in pulmonary arterial hypertension: a controlled trial. Chest 2007; 132:757-763
5. Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002; 165:800-804 (Pubitemid 34229650)
6. Gomberg-Maitland M, Tapson VR, Benza RL. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med 2005; 172:1586-1589 (Pubitemid 43076550)
7. Tapson VF, Bomberg-Maitland M, McLaughlin VV. Safety and efficacy of IV treprostinil for pulmonary arterial hypertension 37. N Engl J Med 2002; 346:896-903